Warburg Research Analysts Give Encavis (CAP) a €7.20 Price Target

Share on StockTwits

Warburg Research set a €7.20 ($8.37) target price on Encavis (ETR:CAP) in a research report released on Thursday. The firm currently has a buy rating on the stock.

A number of other equities research analysts have also recently commented on the company. Commerzbank set a €6.20 ($7.21) price target on Encavis and gave the company a neutral rating in a research note on Friday, September 21st. Berenberg Bank set a €8.70 ($10.12) price target on Encavis and gave the company a buy rating in a research note on Monday, December 3rd. Finally, DZ Bank reiterated a buy rating on shares of Encavis in a research note on Wednesday, December 5th. One analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. Encavis presently has an average rating of Buy and a consensus price target of €7.52 ($8.74).

Encavis stock traded up €0.03 ($0.03) during midday trading on Thursday, reaching €5.62 ($6.53). The company’s stock had a trading volume of 59,937 shares, compared to its average volume of 216,837. Encavis has a 52-week low of €5.85 ($6.80) and a 52-week high of €7.15 ($8.31).

Encavis Company Profile

Capital Stage AG, prior to change in line of business is out of business. The firm is a principal investment firm specializing in operation of solar and onshore-wind energy and parks. It does not focus on investing in Greenfield projects from scratch or take significant development or construction risk.

Further Reading: How to Invest in a Bull Market

Analyst Recommendations for Encavis (ETR:CAP)

Receive News & Ratings for Encavis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encavis and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Biocept  Shares Gap Down to $1.67
Biocept Shares Gap Down to $1.67
VirnetX  Shares Gap Up to $6.33
VirnetX Shares Gap Up to $6.33
Zacks: Brokerages Anticipate Repligen Co.  Will Post Quarterly Sales of $50.33 Million
Zacks: Brokerages Anticipate Repligen Co. Will Post Quarterly Sales of $50.33 Million
Stealth 24-Hour Volume Tops $138.00
Stealth 24-Hour Volume Tops $138.00
Molecular Future  1-Day Volume Tops $421,889.00
Molecular Future 1-Day Volume Tops $421,889.00
Deutsche Lufthansa AG  Receives Consensus Recommendation of “Hold” from Brokerages
Deutsche Lufthansa AG Receives Consensus Recommendation of “Hold” from Brokerages


Leave a Reply

© 2006-2019 Ticker Report